Galderma Group AG (GDERF)

OTCMKTS · Delayed Price · Currency is USD
163.60
+1.50 (0.93%)
Jul 28, 2025, 4:00 PM EDT
0.93%
Market Cap39.60B
Revenue (ttm)4.69B
Net Income (ttm)378.00M
Shares Outn/a
EPS (ttm)1.59
PE Ratio104.75
Forward PE49.60
Dividend0.18 (0.11%)
Ex-Dividend DateApr 25, 2025
Volume900
Average Volume1,031
Open165.00
Previous Close162.10
Day's Range163.60 - 166.50
52-Week Range81.32 - 166.50
Betan/a
RSI98.32
Earnings DateJul 24, 2025

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Actinica, Dysport/Azzalure, Alluzience, Restylane and Restylane Skinboosters, Sculptra, Cetaphil and Alastin, Soolantra, Epiduo and Epiduo Forte, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Mirvaso, Nemluvio, Relfydess, Benzac, Loceryl, and TRI-LUMA in ... [Read more]

Sector Healthcare
Founded 1981
Employees 6,545
Stock Exchange OTCMKTS
Ticker Symbol GDERF
Full Company Profile

Financial Performance

Financial Statements

News

Galderma Announces Departure of Its Chief Financial Officer

ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich, Chief Financial Officer, will be leaving the company t...

4 weeks ago - Business Wire

Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety of ...

4 weeks ago - Business Wire

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Strategic move aims to accelerate innovation and growth in the U.S., Galderma's largest region MIAMI , June 17, 2025 /PRNewswire/ -- Galderma (SIX: GALD), the pure-play dermatology category leader, to...

6 weeks ago - PRNewsWire